Mountain View, CA, United States of America

Mark E Deem

USPTO Granted Patents = 144 

 

Average Co-Inventor Count = 4.0

ph-index = 54

Forward Citations = 13,908(Granted Patents)


Inventors with similar research interests:


Company Filing History:

goldMedal21 out of 53 
 
The Foundry, Inc.
 patents
silverMedal17 out of 2,306 
 
Terumo Kabushiki Kaisha
 patents
bronzeMedal11 out of 235 
 
Medtronic Ardian Luxembourg S.a.r.l.
 patents
49 out of 2,207 
 
Ethicon Endo-surgery, Inc.
 patents
59 out of 29 
 
Satiety, Inc.
 patents
68 out of 130 
 
Evalve, Inc.
 patents
77 out of 33 
 
Xtent, Inc.
 patents
86 out of 9 
 
Miradry, Inc.
 patents
95 out of 13 
 
Emphasys Medical, Inc.
 patents
105 out of 6 
 
Cierra, Inc.
 patents
115 out of 9 
 
Cabochon Aesthetics, Inc.
 patents
125 out of 19 
 
Miramar Labs, Inc.
 patents
135 out of 24 
 
Nuvaira, Inc.
 patents
145 out of 71 
 
Twelve, Inc.
 patents
154 out of 37 
 
Transcend Medical, Inc.
 patents
164 out of 56 
 
Ulthera, Inc.
 patents
173 out of 89 
 
Pulmonx Corporation
 patents
183 out of 32 
 
J.w. Medical Systems Ltd.
 patents
193 out of 17 
 
Foundry Innovation & Research 1, Ltd.
 patents
202 out of 23 
 
Torax Medical, Inc.
 patents
212 out of 23 
 
Holaira, Inc.
 patents
222 out of 48 
 
Medtronic Ireland Manufacturing Unlimited Company
 patents
231 out of 3 
 
Innovative Pulmonary Solutions, Inc.
 patents
241 out of 1,167 
 
Alcon, Inc.
 patents
251 out of 832,680 
Other
 patents

Years Active: 2003-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Therapeutic Agent Delivery
Heart Valve Replacement
Glaucoma Treatment
Renal Neuromodulation
Microwave Therapy
Nerve Tissue Injury
Asthma Treatment
Heart Failure Monitoring
Endoscopic Annuloplasty
Toxin Delivery
Atrial Fibrillation Treatment
Selective Cell Lysis
144 patents (USPTO):Explore Patents

Title: Mark E Deem: A Pioneer in Therapeutic Agent Delivery

Introduction:

Meet Mark E Deem, a renowned innovator and inventor based in Mountain View, CA. With a remarkable track record of 134 patents, Deem has made significant contributions to the field of therapeutic agent delivery. In this article, we will delve into his latest patents, career highlights, and notable collaborations.

Latest Patents:

Deem's latest patents revolve around systems and methods for the delivery of therapeutic agents. Particularly, he focuses on applying fragments of neurotoxins, specifically the active light chain (LC) of the botulinum toxin (BoNT), to produce therapeutic responses in mammalian systems. These innovative methods involve the permeabilization of targeted cell membranes to enable translocation of the BoNT-LC molecule into the cell cytosol. Deem harnesses various delivery systems, including catheter-based, non-invasive, and transdermal approaches, to achieve efficient therapeutic agent delivery.

Career Highlights:

Throughout his illustrious career, Mark E Deem has left an indelible mark on the field of therapeutic agent delivery. Notably, he has contributed to the pioneering work of The Foundry, Inc., a renowned medical device incubator where he played a key role in developing cutting-edge devices and technologies. In collaboration with The Foundry, Inc., Deem's expertise and relentless pursuit of innovation have propelled advancements in therapeutic agent delivery systems.

Collaborations:

Deem has had the privilege of collaborating with esteemed professionals in his field. One notable colleague is Hanson S Gifford, III, an accomplished figure in medical device development. Their collaboration has undoubtedly led to groundbreaking advancements in therapeutic agent delivery systems, setting the stage for future breakthroughs.

Conclusion:

Mark E Deem's extensive patent portfolio is a testament to his significant contributions to the field of therapeutic agent delivery. Through his innovative methods and collaboration with industry leaders, Deem has revolutionized the way therapeutic agents are delivered, paving the way for enhanced treatment options in the medical field. With his relentless pursuit of excellence, we can expect Deem's future endeavors to bring about even more exciting innovations in the realm of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…